Schedule 13G ownership disclosure

ESSA PHARMA INC

Security class unavailable · CUSIP: 29668H104

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,122,973
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-20-000238
Form type
SC 13G/A
Filer
ESSA Pharma Inc.
CIK
CIK 1633932
Filed
Feb 12, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub